The company’s Japan unit began rollouts for the Aurora EV-ICD MRI device and the Epsila EV MRI lead. They comprise the implantable cardioverter defibrillator (ICD) system that performs electrotherapy to restore a heart to a normal rhythm.

Aurora delivers defibrillation, anti-tachycardia pacing (ATP) and backup (pause-prevention) pacing therapies. It features a similar size, shape and longevity to traditional transvenous ICDs. However, the implant goes below the left armpit with the Epsila defibrillation lead placed under the breastbone. Medtronic says this helps avoid certain risks associated with transvenous ICDs that have leads placed inside the blood vessels.